Objective-Insulin resistance renders macrophages more prone to cholesterol-induced apoptosis by promoting nuclear localization of transcription factor forkhead box transcription factor (Fox) O1. However, FoxO1 also decreases macrophage inflammation, raising the question of how the balance between proapoptotic and antiinflammatory effects is determined. We sought to identify the mechanism whereby FoxO1 dampens inflammation without promoting apoptosis. We hypothesized that nutrient-dependent FoxO1 acetylation plays a role in this process. Methods and Results-We generated knock-in mice bearing alleles that encode constitutively deacetylated FoxO1 and studied the ex vivo response of primary peritoneal macrophages. We show that macrophages derived from mice homozygous for constitutively deacetylated FoxO1 alleles retain antiinflammatory properties in response to free cholesterol loading, without increasing apoptosis. Deacetylated FoxO1 inhibits free cholesterol-induced Akt phosphorylation and increases levels of the nuclear factor-B precursor p105, decreasing nuclear translocation of nuclear factor-B p65 subunit and dampening mitogen-activated protein/extracellular signal-regulated kinase activation to prevent inflammation. Conclusion-Deacetylated FoxO1 regulates p105 to prevent macrophage inflammation without causing apoptosis, suggesting a potential novel therapeutic approach to atherosclerosis through FoxO1 deacetylation. (Arterioscler Thromb Vasc Biol. 2011;31:2920-2928.)
C omplications from atherosclerotic cardiovascular disease are a leading cause of death. 1 Macrophage inflammation in the vessel wall is a key event in the formation and rupture of atherosclerotic plaques. Various cytokines produced from lesional macrophages contribute to lesion progression. 2 In early atherosclerosis, macrophages take up modified cholesterol-rich lipoproteins and store their cholesterol largely in esterified form, resulting in foam cell formation. As lesions advance, cholesteryl-ester content drops and unesterified or free cholesterol (FC) rises, 3, 4 likely inducing endoplasmic reticulum (ER) stress and expression of transcription factor Chop. 5 The in vivo relevance of ER stress-mediated Chop induction to atherosclerosis progression is demonstrated by studies in which Chop ablation halved the number of apoptotic lesional macrophages and reduced plaque size in apolipoprotein E Ϫ/Ϫ or low-density lipoprotein receptor Ϫ/Ϫ mice. 6 In addition to ER stress, FC activates the mitogen-activated protein kinase (Mapk, including extracellular signalregulated kinase [Erk]-1/2, Jun N-terminal kinase 1/2, and p38) and I kappa B kinase (Ikk)/nuclear factor (Nf)-B inflammatory pathways, possibly by inducing tumor necrosis factor-␣ (Tnf-␣) and interleukin-6 (Il-6). 7 Macrophages are insulin-sensitive cells. 8 Defective macrophage insulin signaling predisposes to foam cell formation in insulin-resistant states 9 and impairs the ability of macrophages to relieve ER stress, resulting in greater macrophage apoptosis and plaque necrosis within advanced lesions. 10 In macrophages, forkhead box transcription factor (Fox) O1, FoxO3, and FoxO4 appear to have dual functions, promoting apoptosis in the context of ER stress but decreasing inflammation in response to FC 11 or lipopolysaccharide (LPS). 12 FoxO1 activity is regulated by posttranslational modifications to meet the cell's metabolic demand or stress response. 13 Falling nutrient levels activate FoxO1 through dephosphorylation and deacetylation, whereas rising nutrient levels inactivate FoxO1 through Akt-dependent phosphorylation, and Cbp/p300-dependent acetylation. 14 The purpose of this study was to understand the mechanism whereby FoxO1 activation can have effects that are seemingly at odds: more apoptosis and less inflammation. Our goal was to define approaches that leverage the antiinflammatory actions of FoxO1 for therapeutic ends without promoting apoptosis. It has been shown that hyperglycemia in type 2 diabetes leads to FoxO1 acetylation. [15] [16] [17] Acetylation targets FoxO1 to nuclear promyelocytic leukemia bodies, where it undergoes deacetylation to become transcriptionally active. 15 Less clear is the effect of FC signaling on macrophage FoxO1 and the role of FoxO1 acetylation in macrophage activation. To answer these questions, we generated knock-in mice bearing alleles that encode constitutively deacetylated FoxO1 and studied the ex vivo response of primary peritoneal macrophages to FC challenge. Deacetylated FoxO1 prevented FC-induced Akt phosphorylation and increased levels of p105, the precursor protein of Nf-B subunits. p105, in turn, promoted Nf-B p65 and p50 cytoplasmic retention and dampened Erk activation, decreasing inflammation. The data are consistent with a model in which FoxO1 deacetylation can uncouple inflammation from apoptosis in FC-loaded macrophages.
Materials and Methods

Experimental Animals
Acetylation-defective FoxO1 knock-in mice (FoxO1 KR/KR ) have been described. 18
Materials
A detailed list of manufacturers is provided in the supplemental material, available online at http://atvb.ahajournals.org.
Macrophage Culture, FC Loading, Immunoprecipitation, and Immunoblotting
We harvested peritoneal macrophages from FoxO1 ϩ/ϩ or FoxO1 KR/KR mice by peritoneal lavage 3 days after intraperitoneal injection of 4% thioglycolate and cultured them in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 20% L929 cell-conditioned medium. 19 We loaded cells with FC by incubation in medium supplemented with compound 58035 (10 mg/L) and acetylated low-density lipoprotein (100 mg/L) for the indicated time periods. 19 Protein analysis was carried out as described. 11, 16 
Immunocytochemsitry
We performed FoxO1 immunocytochemstry as described. 15 We measured apoptosis by Alexa Fluor 488 -labeled annexin V and propidium iodide staining (Vybrant Apoptosis Assay kit, Invitrogen).
Quantitative Reverse Transcription-Polymerase Chain Reaction and ELISA
We performed quantitative reverse transcription-polymerase chain reaction using DyNAmo HS SYBR Green qPCR Kit (Finnzymes) as described. 15
Adenoviruses
We have described adenoviruses encoding LacZ, green fluorescent protein-tagged FoxO1-wild-type (WT) and FoxO1-KR, hemagglutinintagged FoxO1-ADA, and Nf-B-luciferase. 11, 15, 20, 21 
Luciferase Assays
We measured luciferase activity in peritoneal macrophages transfected with Nf-B reporter construct using the Dual Luciferase Reporter assay system (Promega).
Statistical Analysis
Data are shown as meanϮSE. We determined statistically significant differences (PϽ0.05) using the unpaired t test or ANOVA with the Dunn post hoc test.
Results
FC Loading Induces FoxO1 Acetylation in Peritoneal Macrophages
We examined the effect of FC loading on FoxO1 acetylation and subcellular localization. FC induced FoxO1 acetylation in FoxO1 ϩ/ϩ but not FoxO1 KR/KR macrophages ( Figure 1A ). The latter also showed increased nuclear FoxO1 in the basal state that was unaffected by FC loading, whereas the number of WT macrophages with predominantly nuclear FoxO1 doubled in response to FC loading ( Figure 1B and 1C ). FoxO1 regulation by FC loading in macrophages is reminiscent of its regulation by high glucose/oxidative stress in pancreatic ␤-cells. 15 The findings indicate that FC challenge phenocopies nutrient excess (high glucose) to promote FoxO1 acetylation, whereas deacetylation is required to keep FoxO1 in the nucleus.
Blunted Induction of Inflammatory Cytokines in FC-Loaded FoxO1 KR/KR Macrophages
FC loading increased levels of mRNAs encoding monocyte chemoattractant protein-1 (Mcp-1), Tnf-␣, Il-6, Il-1␤, Rantes, macrophage inflammatory protein-1␣ (Mip-1␣), Mip-1␤, Mip-2, Tgf-␤1, and osteopontin (encoded by Spp1) between 2-and 8-fold in WT macrophages, but these effects were absent (Mcp-1, Tnf-␣, Il-6, Mip-1␤, Mip-2) or blunted (Rantes, Tnf-␣, Il-1␤, Mip-2) in FoxO1 KR/KR macrophages ( Figure  1D ). Levels of Mip-1␣, Tgf-␤1, and Spp1 were decreased also in the basal state in FoxO1 KR/KR macrophages ( Figure 1D ). In contrast, levels of the antiinflammatory cytokine Il-10 were comparable between the 2 genotypes. The changes in mRNA were paralleled by a 5-fold increase in Mcp-1 release in the culture medium in WT macrophages that was totally absent in FoxO1 KR/KR macrophages ( Figure 1E ). Release of Tnf-␣ and Il-6 increased Ͼ100-fold in FoxO1 ϩ/ϩ cells and was blunted by 40% and 60%, respectively, in FoxO1 KR/KR cells ( Figure  1F and 1G).
In contrast, the response of FoxO1 KR/KR macrophages to the Toll-like receptor-2 agonist zymosan, and to the Toll-like receptor-4 agonist LPS did not show a clear-cut antiinflammatory pattern and, in some instances (eg, LPS-stimulated Il-6; zymosan-and LPS-stimulated Tnf-␣ induction) were more pronounced in FoxO1 KR/KR than in FoxO1 ϩ/ϩ macrophages (Supplemental Figure IA and IB).
FoxO1-KR Does Not Increase FC-Induced Apoptosis
FC increases macrophage apoptosis by activating the Chop branch of the unfolded protein response. 5, 6 The phosphorylationdefective mutant FoxO1, FoxO1-ADA (in which the 3 main sites of insulin-induced phosphorylation have been mutated), 22 is constitutively nuclear and exacerbates this effect. 11 As the FoxO1-KR mutant was also predominantly nuclear, we expected it to induce apoptosis. However, we failed to detect differences in Bip and Chop mRNA (Supplemental Figure IIA) , or in the number of apoptotic macrophages in response to FC between FoxO1 ϩ/ϩ and FoxO1 KR/KR cells (Supplemental Figure IIB and IIC). Apoptosis induced by thapsigargin, an inhibitor of the ER Ca 2ϩ pump sarcoplasmic/ER calcium ATPase (Serca) that promotes ER stress, 23 was also comparable between the 2 cell Figure  IID) . These data indicate that FoxO1-KR dampens inflammation without predisposing to apoptosis, a critical difference between it and the phosphorylation-defective mutant.
FoxO1-KR Inhibits FC-Induced Akt Phosphorylation
In view of the role of Akt in modulating the macrophage antiapoptotic and antiinflammatory responses, 27 we examined the effects of FC loading on Akt activity in macrophages. In the early stages of FC loading, Akt phosphorylation on Ser473 and Thr308 was increased in FoxO1 ϩ/ϩ macrophages, but this effect was decreased by Ϸ80% in FoxO1 KR/KR macrophages (Figure 2A-2C ). Phosphorylation of the Akt substrate glycogen synthase kinase 3␤ was also decreased in FoxO1 KR/KR macrophages (Figure 2A and 2D) . In contrast, there was no difference in insulin-induced Akt phosphorylation between the 2 cell types ( Figure 2E-2H ). Thus, Akt activation by FC is selectively impaired in FoxO1 KR/KR macrophages. 
Impaired Mek/Erk Activation in
Distinct Signaling Pathways Are Elicited by Phosphorylation-Defective Versus Acetylation-Defective FoxO1 Mutants
We have previously shown that the phosphorylationdefective FoxO1-ADA has antiinflammatory effects in macrophages. 11 As the FoxO1-KR mutant is also predominantly nuclear (although not to the same extent as the phosphorylation-defective mutant), we considered the possibility that the observed effects might simply reflect a gain of FoxO1 function, and be unrelated to its acetylation state. To investigate this point, we performed ex vivo experiments by transducing primary peritoneal macrophages with FoxO1-WT, FoxO1-ADA (phosphorylation-defective), and FoxO1-KR (acetylation-defective) and measured their response to FC loading. FoxO1-KR and WT-FoxO1 inhibited FC induced Akt phosphorylation on Ser473 and Thr308, whereas FoxO1-ADA increased it (Supplemental Figure  IVA-IVC) . Likewise, FC induced Mek and Erk phosphorylation (Supplemental Figure IVA , IVD, and IVE). FoxO1-WT or FoxO1-ADA had no effect on this response, whereas FoxO1-KR blunted it (Supplemental Figure IVA , IVD, and IVE). These data indicate that deacetylated FoxO1 has a unique effect that modulates inflammatory pathways in FC-loaded macrophages.
FoxO1-KR Impairs Activation of Nf-B by FC
FC loading activated Nf-B signaling in macrophages, 7, 25 stimulating IB␣ phosphorylation on Ser32 in a time- dependent manner. This response was nearly absent in FoxO1 KR/KR macrophages ( Figure 4A ). IB␣ phosphorylation triggers its proteasomal degradation, resulting in Nf-B nuclear translocation. 28 Accordingly, we observed a 2-fold increase in nuclear content of the Nf-B p65 subunit follow-ing FC loading of FoxO1 ϩ/ϩ macrophages ( Figure 4B-4D) .
In contrast, levels of nuclear p65 were unchanged in FCtreated FoxO1 KR/KR macrophages ( Figure 4B-4D ). To correlate these changes with Nf-B function, we assessed the activity of an Nf-B reporter gene transduced into FoxO1 ϩ/ϩ or FoxO1 KR/KR cells. In FoxO1 ϩ/ϩ cells, FC induced an Ϸ8-fold increase of Nf-B-luciferase activity, whereas the effect of FC was decreased by 40% in FoxO1 KR/KR cells ( Figure 4E ).
Identification of p105 (Nfkb1) as Mediator of the Anti-Inflammatory Effects of FoxO1-KR
The combined impairment of Nf-B and Mek/Erk activities in FoxO1 KR/KR macrophages led us to formulate the testable hypothesis that a shared regulator of both pathways was responsible for this reduction. The product of the Nfkb1 gene, p105, is the precursor of Nf-B p50 29 and functions as an IB-like molecule by sequestering p65, p50, and c-Rel in the cytoplasm 30 -32 and preventing their binding to DNA. 31 p105 also inhibits the Mek/Erk pathways by forming stoichiometric complexes with the Mek inhibitor tumor progression locus-2/Cot. 32 We detected a 4-fold increase in p105 protein levels ( Figure 5A and 5B) , associated with a 2-fold rise of cytosolic p50 levels in FoxO1 KR/KR macrophages ( Figure 5C ), consistent with increased extranuclear retention of this subunit. In contrast, nuclear levels of p50 increased only by Ϸ30% in FoxO1 KR/KR cells ( Figure 5D ). The increase of p105 protein was associated with a 30% rise of Nfkb1 mRNA in FoxO1 KR/KR macrophages ( Figure 5E ), suggesting that the main mechanism of increased p105 levels is not increased Nfkb1 transcription. Transduction of FoxO1-KR adenovirus in primary peritoneal macrophages also increased p105 protein levels ( Figure 5F ), albeit to a lower extent, probably reflecting the limited efficiency of adenoviral transduction compared with studying a homogeneous population of FoxO1 KR/KR macrophages. The increase was independent of changes in Nfkb1 mRNA (data not shown), consistent with a transcription-independent mechanism. In contrast, FoxO1-WT and FoxO1-ADA had no effect on p105 ( Figure  5F and 5G) . These data indicate that p105 is a specific, albeit indirect (nontranscriptional) target of deacetylated FoxO1.
Phosphatidylinositol 3-Kinase Inhibition Mimics the Effect of FoxO1-KR on p105
Akt phosphorylates Ikk, 33, 34 triggering p105 proteolysis and Nf-B/Mek/Erk activation. In addition, the Akt substrate glycogen synthase kinase-3␤ stabilizes p105 through phosphorylation, preventing its degradation. 35 We reasoned that if FoxO1-KR increased p105 by inhibiting Akt, its effects should be phenocopied by pharmacological inhibition of phosphatidylinositol 3-kinase. Indeed, the phosphatidylinositol 3-kinase inhibitor LY294002 inhibited Akt phosphorylation and glycogen synthase kinase 3␤ phosphorylation and increased p105 protein levels ( Figure 6A and 6B) indepen- 
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dently of mRNA ( Figure 6C ). LY294002 also inhibited FC-induced Mcp-1, Tnf-␣, IL-6, IL-1␤, Mip-1␤, and Mip-2 expression in macrophages ( Figure 6D ). In contrast, Mip-1␣, Tgf-␤1, and Spp1, whose induction by FC was blunted in FoxO1 KR/KR macrophages, were unaffected by LY294002 ( Figure 6D ). These data provide indirect support for the hypothesis that the antiinflammatory effects of FoxO1-KR are mediated by its ability to decrease Akt phosphorylation.
FoxO1-KR Does Not Act Through IB, the Main Target Gene of FoxO1-ADA
We have previously shown that phosphorylation-deficient FoxO1-ADA blunts Nf-B activation by FC and increases IB expression, 11 leading to p65 retention in the cytoplasm. 28,36 -38 In the light of this precedent, we considered the possibility that FoxO1-KR regulated expression of IB␣, IB␤, and IB (Supplemental Figure VA) . Consistent with prior observations, FC loading increased IB levels Ϸ4fold, whereas IB␣ and IB␤ levels were unaffected (Supplemental Figure VA ). However, IB induction was similar in FoxO1 ϩ/ϩ and FoxO1 KR/KR macrophages (Supplemental Figure VA) . We also examined the ability of FoxO1-WT, FoxO1-ADA, and FoxO1-KR to regulate the 3 IBs in primary macrophages. Only FoxO1-ADA significantly increased IB, 11 whereas neither FoxO1-WT nor FoxO1-KR affected any of the 3 IBs (Supplemental Figure VB) . These data support the conclusion that FoxO1-KR inhibits FCinduced Nf-B activity independent of IB and provide more evidence for a deacetylation-specific mechanism of reduced inflammation.
Discussion
The pathogenesis of inflammation in cardiovascular atherosclerotic disease is multifactorial and involves generation of cytokines, free radical formation, hemodynamic stress, hypertension, infections, and accumulation of oxidized phospholipids and 7-oxysterols. 39, 40 FC accumulation in macrophages promotes inflammation through cytokine production, 7, 11, 25 leading to increased levels of adhesion molecules and tissue factor 41 and migration of vascular smooth muscle cells. 42 We now show that FC increases FoxO1 acetylation and that constitutively deacetylated FoxO1 15 prevents FCinduced inflammation without promoting apoptosis. The latter finding sets this FoxO1 mutant apart from a phosphorylation-defective mutant that we have previously shown to inhibit inflammation and promote FC-dependent apoptosis. 11 Interestingly, constitutively active Akt prevents FC-induced macrophage apoptosis in insulin-resistant macrophages, 11 whereas phosphatidylinositol 3-kinase/Akt inhibition by LY294002 increases it. These findings suggest that FoxO1-KR activates additional antiapoptotic pathways to offset its proapoptotic properties macrophages. As FoxO1 phosphorylation and acetylation are regulated in response to different physiological cues and disease states, 13 the present findings have implications that go beyond the FC loading model. We propose a novel mechanism to explain the findings (Supplemental Figure VI) . FoxO1 deacetylation blocks FCdependent Akt phosphorylation, leading to decreased Ikk/ Nf-B and Mek/Erk activation, reduced cytokine expression, and reduced inflammation. We identify the product of the Nfkb1 gene p105 as a nontranscriptional target of deacetylated FoxO1 that potentially mediates its antiinflammatory effects. The data provide further evidence that deacetylation fine-tunes FoxO1 function through target gene selection; thus, the phosphorylation-defective and acetylation-defective mutants have opposite effects on Akt phosphorylation and selective effects on Nfkb1 and IB expression. 11, 21 Identifying the mechanism of the differential effects on Akt phosphorylation poses a daunting challenge for future work, as does the identification of coregulatory mechanisms whereby FoxO proteins can regulate gene expression without direct DNA binding. 20 Akt regulates inflammation 33, [43] [44] [45] by phosphorylating Ikk␣ on Thr23 and activating Nf-B. 45 Pharmacological inhibition of Ikk increases p105 levels, and inhibits LPSstimulated Nf-B and Mek/Erk activation in macrophages. 30 On the other hand, p105 gain-of-function fails to affect LPS-induced Nf-B and Mek/Erk signaling, 30 suggesting that this mechanism is specific for certain inflammatory stimuli, but not all inflammatory stimuli. Consistent with this observation, we have observed that FoxO1 KR/KR macrophages are resistant to FC-induced but not to zymosan-or LPS-induced activation of inflammatory cytokines. It is also of interest to note that pharmacological inhibition of phosphatidylinositol 3-kinase-Akt mimics the FoxO1-KR effect to raise p105 levels but has narrower effects on cytokine induction by FC, suggesting that not all effects of FoxO1-KR can be explained by its inhibition of Akt. We propose that decreased Akt activity by FoxO1-KR attenuates p105 proteolysis by 2 separate mechanisms: Ikk inhibition, leading to Nf-B and Mapk inhibition; and decreased glycogen synthase kinase 3␤ phosphorylation, which has been shown to prevent constitutive processing/degradation of p105 by increasing its stability. 35 The present study confirms the biphasic activation pattern of Mek and Erk. 46, 47 This could be due to delayed activation of certain subsets of Mapks or to autocrine signaling by cytokines produced from FC-stimulated macrophages, such as CXC-ligand 4 and IL-10. 48, 49 The role of FoxO1 in the development of atherosclerosis varies in different cells and tissue types. Insulin receptordeficient macrophages, in which FoxO1 is constitutively active, display antiinflammatory responses to FC 11 and LPS 12 but are prone to apoptosis. 10 Conversely, in vascular endothelial cells, FoxO1 gain-of-function promotes peroxynitrite and reactive oxygen species generation, 16 predisposing to inflammation. This finding is consistent with the observation that endothelial-cell specific ablation of insulin receptors (a condition associated with increased nuclear FoxO1) in apolipoprotein E Ϫ/Ϫ mice worsens atherosclerosis, 50 as does Akt1 ablation, 51 pinpointing vascular endothelial cells as a key site of atherosclerotic lesion development in insulin resistance.
In conclusion, our study demonstrates that FoxO1 deacetylation is an important regulatory mechanism in cholesterolladen macrophages, with the potential to uncouple inflammation from apoptosis. As these mechanisms underlie the progression of atherosclerotic plaques from benign to unstable lesions, 2 it can be envisioned that treatments promoting FoxO1 deacetylation will favorably affect cardiovascular outcomes in type 2 diabetes.
